Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Cymab ApS
APS
Active
CVR 39859173
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 7 years old
2 ansatte
Overvåg
Share
Danmark
/
Virksomheder
/
Manufacture of pharmaceutical preparations
/
Cymab ApS
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Personer & ejerskab
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
JH
Johan Henrik Faber
Chief Executive Officer
Chief Executive Officer
2023
Tidligere (3)
AR
Anne Reker Cordt
Management
Management
2024 – 2026
SL
Stine Louise Reedtz Kjellev
Management
Management
2023 – 2024
KF
Kurt Flemming Holmsted
Management
Management
2018 – 2019
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (4)
SE
Søren Erik Bjørn
Board of Directors
Board of Directors
2020
TD
Thomas Dal Stenfeldt Batchelor
Board of Directors
Board of Directors
2023
HH
Hans Heugh Wandall
Chairman
Chairman
2023
MN
Mads Nikolaj Behrndt-Eriksen
Board of Directors
Board of Directors
2023
Tidligere (1)
KS
Kim Stengaard Holmsted
Chairman
Chairman
2018 – 2020
Aktionærer
Pr. seneste årsrapport
100%
Shareholder
Type
Ownership
Votes
Since
Ebumab Holding ApS
Company
100%
100%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Mere om Cymab ApS
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Regnskaber & nøgletal →
Omsætning, EBITDA, balance og 5-års udvikling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk